Search research articles
Contact Us
Filters
Showing results (161-170 of 192) with videos related to
Page
of 20
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 21, 2005
Single agent rituximab in patients with follicular or mantle cell lymphoma: clinical and biological factors that are predictive of response and event-free survival as well as the effect of rituximab on the immune system: a study of the Swiss Group for Clinical Cancer Research (SAKK)
M Ghielmini, K Rufibach, G Salles, et al.
Journal of Clinical Pharmacy and Therapeutics
|
January 17, 2015
EPICC study: evaluation of pharmaceutical intervention in cancer care
N Vantard, F Ranchon, V Schwiertz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 1999
International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: report of the jury
M A Shipp, M D Abeloff, K H Antman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 12, 2012
Rituximab induction immunotherapy for first-line low-tumor-burden follicular lymphoma: survival analyses with 7-year follow-up
P Colombat, N Brousse, G Salles, et al.
The Hematology Journal : the Official Journal of the European Haematology Association
|
March 29, 2002
Tumor necrosis factor alpha release is a major biological event associated with rituximab treatment
J Bienvenu, R Chvetzoff, G Salles, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 17, 1999
International Consensus Conference on high-dose therapy with hematopoietic stem-cell transplantation in aggressive non-Hodgkin's lymphomas: report of the jury
M A Shipp, M D Abeloff, K H Antman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 4, 2005
Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte
P Feugier, A Van Hoof, C Sebban, et al.
Bone Marrow Transplantation
|
February 4, 2014
High burden of BK virus-associated hemorrhagic cystitis in patients undergoing allogeneic hematopoietic stem cell transplantation
L Gilis, S Morisset, G Billaud, et al.
Alimentary Pharmacology & Therapeutics
|
December 14, 1999
Omeprazole, clarithromycin and furazolidone for the eradication of Helicobacter pylori in patients with duodenal ulcer
R Dani, D M Queiroz, M G Dias, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 15, 2007
Peripheral blood natural killer cell count is associated with clinical outcome in patients with aaIPI 2-3 diffuse large B-cell lymphoma
A Plonquet, C Haioun, J-P Jais, et al.
Page
of 20
Search research articles
Search
Showing results (161-170 of 192) with videos related to
Sort By:
Page
of 20
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 21, 2005
Single agent rituximab in patients with follicular or mantle cell lymphoma: clinical and biological factors that are predictive of response and event-free survival as well as the effect of rituximab on the immune system: a study of the Swiss Group for Clinical Cancer Research (SAKK)
M Ghielmini, K Rufibach, G Salles, et al.
Journal of Clinical Pharmacy and Therapeutics
|
January 17, 2015
EPICC study: evaluation of pharmaceutical intervention in cancer care
N Vantard, F Ranchon, V Schwiertz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 1999
International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: report of the jury
M A Shipp, M D Abeloff, K H Antman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 12, 2012
Rituximab induction immunotherapy for first-line low-tumor-burden follicular lymphoma: survival analyses with 7-year follow-up
P Colombat, N Brousse, G Salles, et al.
The Hematology Journal : the Official Journal of the European Haematology Association
|
March 29, 2002
Tumor necrosis factor alpha release is a major biological event associated with rituximab treatment
J Bienvenu, R Chvetzoff, G Salles, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 17, 1999
International Consensus Conference on high-dose therapy with hematopoietic stem-cell transplantation in aggressive non-Hodgkin's lymphomas: report of the jury
M A Shipp, M D Abeloff, K H Antman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 4, 2005
Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte
P Feugier, A Van Hoof, C Sebban, et al.
Bone Marrow Transplantation
|
February 4, 2014
High burden of BK virus-associated hemorrhagic cystitis in patients undergoing allogeneic hematopoietic stem cell transplantation
L Gilis, S Morisset, G Billaud, et al.
Alimentary Pharmacology & Therapeutics
|
December 14, 1999
Omeprazole, clarithromycin and furazolidone for the eradication of Helicobacter pylori in patients with duodenal ulcer
R Dani, D M Queiroz, M G Dias, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 15, 2007
Peripheral blood natural killer cell count is associated with clinical outcome in patients with aaIPI 2-3 diffuse large B-cell lymphoma
A Plonquet, C Haioun, J-P Jais, et al.
Page
of 20